COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials
Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here’s what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.
UF Health in Gainesville Begins Vaccinating High-Risk Health Care Employees Against COVID-19
University of Florida Health clinical caregivers who are most at risk of being exposed to the novel coronavirus that causes COVID-19 began receiving vaccinations at the UF Health Shands Cancer Hospital, just two days after the first vaccinations in the state were administered at UF Health Jacksonville
PanVent Emergency Ventilator Created to Fill Urgent Need During COVID-19
Dr. Samsun Lampotang has spent his career engineering solutions to medical problems. At the start of 2020, Lampotang’s focus was on designing, building and validating mixed reality guided intervention simulators to train physicians and nurses in medical procedures without putting patients at risk. But then COVID-19 changed all this.
UF Health Jacksonville CEO Believed to Be First in Florida to Receive COVID-19 Vaccine
The CEO of UF Health Jacksonville is believed to be the first person in the state of Florida to receive the Pfizer-BioNTech COVID-19 vaccine.
CBS4’s Elliot Rodriguez Sits With Dr. David Ostrov and Talk About Antihistamine Drugs That Can Be Affective Against Coronavirus
A new study at the University of Florida suggests 3 common antihistamine drugs can be affective against coronavirus. Elliot Rodriguez sat with Dr. David Ostrov to discuss the topic.
Existing Antihistamine Drugs Show Effectiveness Against COVID-19 Virus in Cell Testing
Three common antihistamine medications have been found in preliminary tests to inhibit infection of cells by the coronavirus that causes COVID-19, University of Florida Health researchers have found.
UF Researcher Finds a Way to Mitigate Acute Respiratory Distress Syndrome (ARDS), a Complication of Coronavirus Infection
Why would a doctor specializing in gastrointestinal disorders be interested in therapy for COVID-19, a primarily pulmonary disease? The answer lies in a seemingly convoluted link between the gastrointestinal tract and the lungs: water.
Ology Bioservices Awarded $37 Million for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million.
Oragenics CEO Alan Joslyn Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal
The Tampa Bay Business Journal recognized Alan Joslyn, president and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, for being part of the region’s top health care innovators. The feature was part […]
Blood Biomarkers for Detecting Brain Injury in COVID-19 Patients
COVID-19 can directly cause neurologic symptoms and long-term neurological disease.